“喝完一杯睁眼到天亮”，知名茶饮上热搜，上海禁毒发文

Core Viewpoint - The stock of Bawang Chaji experienced a significant drop of over 14%, marking its largest single-day decline since its listing, following allegations regarding the caffeine content in its beverages being compared to drugs [1][4]. Group 1: Company Response - Bawang Chaji officially responded to the rumors, stating that they are untrue and that legal action has been initiated to protect the company's reputation [3]. - The company emphasized that the caffeine content in their tea drinks is comparable to that of a latte and significantly lower than that of an Americano, based on existing public data and testing results [3]. Group 2: Caffeine Content and Health Implications - Each tea drink from Bawang Chaji is made with original leaf tea and natural ingredients, with caffeine levels accessible to consumers via a "health calculator" on their app before purchase [5]. - Previous incidents have raised concerns about caffeine sensitivity, with reports of consumers experiencing discomfort after consuming certain products, highlighting individual differences in caffeine tolerance [8]. - Caffeine is a natural alkaloid found in tea, which serves to protect the tea plant from pests, and all true teas contain caffeine, with dry tea leaves having a higher caffeine content than coffee beans [9]. Group 3: Regulatory and Safety Standards - The Shanghai Anti-Drug Office clarified that caffeine, when consumed in moderation, is safe, and the caffeine levels in Bawang Chaji's products fall within acceptable limits as per market standards [11]. - According to dietary guidelines, adults can safely consume up to 1524g of liquid milk tea daily without exceeding caffeine limits from other sources [13].